2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions

View by Date

Monday, June 4, 2018

6:00pm-7:00pm: Mycoplasma hominis Infection in Lung Transplant Recipients: A Retrospective Case Series

J. Wright,^1,2 N. Law,⁴ M. Murray, S. Poutanen,^1,2 S. Husain,¹ S. Keshavjee,¹ L. Singer,¹ A. Humar,¹ D. Kumar.¹

Poster Session C: Lung: All Topics • Hall 4EF

6:00pm-7:00pm: 10-Year Outcomes of Renal Transplantation from Circulatory Death Donors with Increased Terminal Creatinine

Y. Tomita, K. Iwadoh, I. Nakajima, S. Fuchinoue.

Poster Session C: Kidney Donor Selection / Management Issues • Hall 4EF

6:00pm-7:00pm: 12-Months Evolution of Anti-HLA Antibodies Donor Specific Antibodies after Rescue Switch from CNi-Based Immunosuppressive Regimen to Belatacept in Kidney Allograft Recipients

M. Matignon,¹ C. Dudreuilh,¹ P. Rémy,¹ J-.L. Taupin,² P. Grimbert.¹

Poster Session C: Kidney Immunosuppression: Novel Regimens and Drug Minimization • Hall 4EF

6:00pm-7:00pm: A “Multi-Omic” Analysis of Proteome and Metabolome for Acute Rejection and PVAN in Kidney Transplantation

T. Sigdel, J. Yang, M. Sarwal.

Poster Session C: Kidney: Polyoma • Hall 4EF

6:00pm-7:00pm: A Machine Learning Approach for Prediction of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients

S. Kawakita,¹ A. Waterman,^1,2 M. Everly.¹

Poster Session C: Kidney Donor Selection / Management Issues • Hall 4EF

6:00pm-7:00pm: A National Survey of Valganciclovir Dosing Strategies in Pediatric Solid Organ Transplant Recipients

S. Shaikh, N. Panek, J. Park.

Poster Session C: Transplant Infectious Diseases • Hall 4EF

6:00pm-7:00pm: A Novel Combined Formula to Direct Optimal Immunosuppressive Drug Exposure in Renal Transplant Recipients

O. Pankewycz,¹ E. Onan,² M. Laftavi,¹ R. Gruessner,³ H. Smileuski,¹ E. Alissandrello,¹ A. Gruessner.³

Poster Session C: Kidney Immunosuppression: Novel Regimens and Drug Minimization • Hall 4EF

6:00pm-7:00pm: A Novel Protocol to Improve Kidney Transplant Outcomes in Patients with Renal Disease Due to Amyloidosis

A. Langone, B. Concepcion, D. Slosky, R. Cornell, S. Horst, S. Goodman.

Poster Session C: Kidney Immunosuppression: Novel Regimens and Drug Minimization • Hall 4EF

6:00pm-7:00pm: A Retrospective Review of De Novo Coccidioidomycosis among Remote Solid Organ Transplant Recipients in Arizona

T. Zangeneh,¹ J. August,¹ N. Beatty,¹ K. Asbury,² L. Mi,² J. Blair.²

Poster Session C: Transplant Infectious Diseases • Hall 4EF

6:00pm-7:00pm: A Six-Month, Prospective, Single-Center, Pilot Study to Determine the Pharmacokinetics and Effectiveness of Immunosuppressant Regimens in Liver Transplantation Patients Receiving Twice-Daily Tacrolimus and Everolimus (TAC + EVR BID) Regimen Converted to Once-Daily Tacrolimus and Everolimus (TAC + EVR QD) Regimen – A Priliminary Report

T-.H. Wu, C-.H. Cheng, Y-.C. Wang, C-.F. Lee, T-.J. Wu, H. Chou, K-.M. Chan, W-.C. Lee.

Poster Session C: Liver: Immunosuppression and Rejection • Hall 4EF